Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double‐blind, non‐inferiority trial

AIM: To assess the efficacy and safety of add‐on therapy with the dipeptidyl peptidase‐4 inhibitor teneligliptin compared with sitagliptin in patients with type 2 diabetes (T2DM) inadequately controlled with metformin and glimepiride. MATERIALS AND METHODS: This was a phase 3, randomized, double‐bli...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yonghyun, Kang, Eun Seok, Jang, Hak Chul, Kim, Dong Jun, Oh, Taekeun, Kim, Eun Sook, Kim, Nan‐Hee, Choi, Kyung Mook, Kim, Sung‐Rae, You, JiYoung, Kim, Se‐Jin, Lee, Moon‐Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587707/
https://www.ncbi.nlm.nih.gov/pubmed/30362280
http://dx.doi.org/10.1111/dom.13566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587707/
https://www.ncbi.nlm.nih.gov/pubmed/30362280
http://dx.doi.org/10.1111/dom.13566

Ejemplares similares